Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma? Ya-Nan JinHui-Jiao CaoLiang-Ping Xia Original Article – Clinical Oncology 07 October 2021 Pages: 2569 - 2579
Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma Felix SchriegelSabine Taschner-MandlKaroline Ehlert Original Article – Clinical Oncology Open access 08 October 2021 Pages: 2581 - 2588
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study Hao WeiXiaojuan ZhouYongmei Liu Original Article – Clinical Oncology 20 October 2021 Pages: 2589 - 2598
Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms Samantha O‘Hagan HendersonJochen J. FrietschJochen Casper Original Article – Clinical Oncology Open access 21 October 2021 Pages: 2599 - 2609
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial Martina Broecker-PreussNina Becher-BovelethUlrich Dührsen Original Article – Clinical Oncology Open access 27 October 2021 Pages: 2611 - 2621
Functional gland-preserving surgery for submandibular gland pleomorphic adenoma Jong-Lyel Roh Original Article – Clinical Oncology 27 October 2021 Pages: 2623 - 2629
Natural history of Von Hippel–Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study Jie WangLei ZhangLiqun Zhou Original Article – Clinical Oncology 28 October 2021 Pages: 2631 - 2641
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients Lihua YuLulu HuangLihua Yang Original Article – Clinical Oncology Open access 01 November 2021 Pages: 2643 - 2652
TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients Xia FangGang WuShaoyong Gao Original Article – Clinical Oncology 02 November 2021 Pages: 2653 - 2660
Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer Xuetian GaoLing PengJisheng Li Original Article – Clinical Oncology 08 November 2021 Pages: 2661 - 2671
Protein expression of prognostic genes in primary melanoma and benign nevi T. GambichlerJ. ElferingL. Susok Original Article – Clinical Oncology Open access 10 November 2021 Pages: 2673 - 2680
Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules Jianzhu XieZheng RuanQian Huang Original Article – Clinical Oncology 17 November 2021 Pages: 2681 - 2692
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera Carl C. CrodelKathleen Jentsch-UllrichFlorian H. Heidel Original Article – Clinical Oncology Open access 22 November 2021 Pages: 2693 - 2705
Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology Lena JosfeldLara KrügerJutta Hübner Original Article – Clinical Oncology Open access 23 November 2021 Pages: 2707 - 2715
Detection and treatment of lung adenocarcinoma at pre-/minimally invasive stage: is it lead-time bias? Zelin MaZezhou WangHaiquan Chen Original Article – Cancer Research 07 May 2022 Pages: 2717 - 2722
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status Josien C. A. JenniskensKelly OffermansPiet A. van den Brandt Original Article – Cancer Research Open access 11 May 2022 Pages: 2723 - 2742
Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model Said Ahmed BahwalJane J. ChenXingwang Zhou Original Article – Cancer Research 12 May 2022 Pages: 2743 - 2757
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro Joseph KauerMelanie MärklinJonas S. Heitmann Original Article – Cancer Research Open access 13 May 2022 Pages: 2759 - 2771
Deep learning combined with radiomics for the classification of enlarged cervical lymph nodes Wentao ZhangJian PengShengsheng Xu Original Article – Cancer Research 13 May 2022 Pages: 2773 - 2780
Trends of cancer mortality in Xi’an City, China: 2005–2020 Ning ChenXiao-Yu ZhangYu-Xiang Yan Original Article – Cancer Research 14 May 2022 Pages: 2781 - 2792
Expression changes in ion channel and immunity genes are associated with glioma-related epilepsy in patients with diffuse gliomas Lianwang LiChuanbao ZhangTao Jiang Original Article – Cancer Research 18 May 2022 Pages: 2793 - 2802
M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer Xue LiuChangsheng MaJudong Luo Original Article – Cancer Research 20 May 2022 Pages: 2803 - 2814
Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases Robert DammMaciej PechBorna Relja Original Article – Cancer Research Open access 21 May 2022 Pages: 2815 - 2826
Evaluating risk factors for lung cancer among never-smoking individuals using two Australian studies Elvin S. ChengMarianne F. WeberXue Qin Yu Original Article – Cancer Research Open access 27 May 2022 Pages: 2827 - 2840
NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN) Takeshi KajiwaraTomohiro NishinaIchinosuke Hyodo Original Article – Cancer Research 27 May 2022 Pages: 2841 - 2854
Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database Dong-sook KimHyun Jung KimHyeong Sik Ahn Original Article – Cancer Research 04 June 2022 Pages: 2855 - 2865
The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer Chun LiuChenxi HuXiaodong Jiang Original Article – Cancer Research 07 June 2022 Pages: 2867 - 2879
Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1 Jayanta K. DasAlok DeorajQuentin Felty Original Article – Cancer Research 09 June 2022 Pages: 2881 - 2891
The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer Monyse de NóbregaMariana Bisarro dos ReisIlce Mara de Syllos Cólus Review – Cancer Research 04 August 2022 Pages: 2893 - 2910
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review Hongyan LiaoJiang YuQin Zheng Review – Clinical Oncology 06 August 2022 Pages: 2911 - 2919
Does first-line immunotherapy impact the efficacy of later treatments: a discussion on the use of second progression-free survival as a research endpoint Zhening ZhangLin ShenZhi Peng Correspondence 14 June 2022 Pages: 2921 - 2924
What would one of the greatest natural scientists and educators of the eighteenth century, Georg Christoph Lichtenberg, say about the current therapy management of patients with penile cancer? Florian A. DistlerSascha PahernikMatthias May Correspondence 21 June 2022 Pages: 2925 - 2927
Two cases of EBV infection preceding lymphoma Jonas SaalBusher AboudanAnnkristin Heine Correspondence Open access 22 June 2022 Pages: 2929 - 2932
A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma Chujie BaiLu ZhangZhengfu Fan Correspondence 07 August 2022 Pages: 2933 - 2937
Answer to the letter by Frass et al. to our systematic review J. HübnerCh. Lübbers Correspondence Open access 09 August 2022 Pages: 2939 - 2941
Homeopathy effects in patients during oncological treatment Michael FrassKonstantin ZhigalovPetra Weiermayer Correspondence 09 August 2022 Pages: 2943 - 2944